DK1426764T3 - Fremgangsmåde til diagnosticering eller monitorering af fejl i sukkermetabolisme - Google Patents

Fremgangsmåde til diagnosticering eller monitorering af fejl i sukkermetabolisme

Info

Publication number
DK1426764T3
DK1426764T3 DK02762796.7T DK02762796T DK1426764T3 DK 1426764 T3 DK1426764 T3 DK 1426764T3 DK 02762796 T DK02762796 T DK 02762796T DK 1426764 T3 DK1426764 T3 DK 1426764T3
Authority
DK
Denmark
Prior art keywords
diagnosing
sugar metabolism
monitoring errors
gbp28
diabetes
Prior art date
Application number
DK02762796.7T
Other languages
English (en)
Inventor
Motowo Tomita
Yasuko Nakano
Hiroshi Hirose
Koichi Matsubara
Original Assignee
Fujirebio Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio Kk filed Critical Fujirebio Kk
Application granted granted Critical
Publication of DK1426764T3 publication Critical patent/DK1426764T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
DK02762796.7T 2001-08-17 2002-08-16 Fremgangsmåde til diagnosticering eller monitorering af fejl i sukkermetabolisme DK1426764T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001248047 2001-08-17
PCT/JP2002/008331 WO2003016906A1 (fr) 2001-08-17 2002-08-16 Procede de diagnostic ou de controle d'une erreur du metabolisme du saccharose

Publications (1)

Publication Number Publication Date
DK1426764T3 true DK1426764T3 (da) 2011-06-27

Family

ID=19077272

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02762796.7T DK1426764T3 (da) 2001-08-17 2002-08-16 Fremgangsmåde til diagnosticering eller monitorering af fejl i sukkermetabolisme

Country Status (10)

Country Link
US (2) US7067634B2 (da)
EP (1) EP1426764B1 (da)
JP (1) JP3624216B2 (da)
AT (1) ATE504001T1 (da)
AU (1) AU2002328630B2 (da)
CA (1) CA2459489C (da)
DE (1) DE60239622D1 (da)
DK (1) DK1426764T3 (da)
ES (1) ES2361663T3 (da)
WO (1) WO2003016906A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE534903T1 (de) 2003-03-24 2011-12-15 Mitsubishi Chem Medience Corp Latex-reaktionsmittel zur adiponectinanalyse und verfahren zur adiponectinanalyse
EP1627229A2 (en) * 2003-04-29 2006-02-22 Cytos Biotechnology AG Methods and compositions for modulating the interaction between adiponectin and its receptor
WO2005094200A2 (en) 2003-06-20 2005-10-13 University Of Florida Biomarkers for differentiating between type 2 and type 2 diabetes
US7176292B2 (en) * 2003-09-11 2007-02-13 Dialean, Ltd. Ghrelin variant protein
CN1867828B (zh) * 2003-10-15 2010-09-29 第一化学药品株式会社 脂连蛋白多聚体的分离测定方法
US7781171B2 (en) 2003-10-15 2010-08-24 Daiichi Pure Chemicals Co., Ltd. Mehod of pretreating sample and immunological assay method using the same
WO2005046734A1 (en) 2003-11-07 2005-05-26 Merck & Co., Inc. Method of identifying responders to treatment with insulin sensitizers
WO2005092367A1 (ja) * 2004-03-29 2005-10-06 Fuji Oil Company, Limited アディポネクチン分泌促進組成物
ATE515699T1 (de) * 2004-03-31 2011-07-15 Kazuhisa Maeda Verwendung von adiponectin als marker in der vorhersage post-operativer infektion
JP2008528694A (ja) * 2005-02-02 2008-07-31 ミトス・ファーマシューティカルズ・インコーポレーテッド 糖尿病の治療または予防において使用するためのニトロキシド類
GB0617429D0 (en) 2006-09-05 2006-10-18 Electrophoretics Ltd Markers of renal transplant rejection and renal damage
WO2009070350A1 (en) * 2007-11-30 2009-06-04 Siemens Healthcare Diagnostics Inc. Adiponectin receptor fragments and methods of use
CN102388308B (zh) 2009-04-23 2015-08-19 西门子医疗保健诊断公司 单体和二聚形式的脂连蛋白受体片段和使用方法
AU2010245543B2 (en) 2009-05-07 2015-08-13 Otsuka Pharmaceutical Co., Ltd. Novel monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same
JP5048100B2 (ja) 2010-04-28 2012-10-17 シャープ株式会社 アディポネクチンに対する結合性を有するペプチド、ならびに該ペプチドを用いた分析方法および分析装置
RU2553943C1 (ru) * 2014-05-27 2015-06-20 Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения Российской Федерации (ГБОУ ВПО МГМУ им. И.М. Сеченова) Способ диагностики инсулинорезистентности

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69837678T2 (de) 1997-10-29 2007-12-27 Otsuka Pharmaceutical Co., Ltd. Compositions zur inhibierung der proliferation glatter muskulatur und verfahren zur diagnose von arteriosklerose
WO2001032868A1 (en) * 1999-11-04 2001-05-10 Genset Apm1 biallelic markers and uses thereof

Also Published As

Publication number Publication date
CA2459489A1 (en) 2003-02-27
JP3624216B2 (ja) 2005-03-02
EP1426764B1 (en) 2011-03-30
US7067634B2 (en) 2006-06-27
DE60239622D1 (de) 2011-05-12
CA2459489C (en) 2010-02-02
US7435551B2 (en) 2008-10-14
ES2361663T3 (es) 2011-06-21
EP1426764A4 (en) 2005-12-14
AU2002328630B2 (en) 2005-09-01
WO2003016906A1 (fr) 2003-02-27
US20050048565A1 (en) 2005-03-03
JPWO2003016906A1 (ja) 2004-12-02
EP1426764A1 (en) 2004-06-09
US20050266506A1 (en) 2005-12-01
ATE504001T1 (de) 2011-04-15

Similar Documents

Publication Publication Date Title
DK1426764T3 (da) Fremgangsmåde til diagnosticering eller monitorering af fejl i sukkermetabolisme
Marshall et al. Standardization of HbA1c measurements: a consensus statement
Giacomello et al. Current methods for stress marker detection in saliva
DK1342794T3 (da) Fremgangsmåde og anordning til at bestemme vævsspecificitet af fritflydende DNA i legemsvæsker
EP1845363A3 (en) Sample analyzer
EP2124053A1 (en) Biological information acquisition method and instrument, and physiologically-active substance measurement method and instrument
DK1574858T3 (da) Analyttestsystem til at bestemme koncentrationen af en analyt i fysiologiske eller vandige fluider
ES2543001T3 (es) Prueba de embarazo
WO2006069023A3 (en) Assay method and apparatus with reduced sample matrix effects
WO2005121362A3 (en) Method for selectively quantifying vegf isoforms in a biological sample and uses thereof.
WO2005071407A3 (en) Methods of diagnosing acute coronary syndrome by measuring urotensin ii
Harp et al. Development of an age‐adjusted model for blood neurofilament light chain
EP1571160A4 (en) KIT FOR THE STUDY OF HUMAN LOW MOLECULAR WEIGHT CD14 AND ANTIBODIES
Mikkonen et al. Microfluidic isoelectric focusing of amyloid beta peptides followed by micropillar-matrix-assisted laser desorption ionization-mass spectrometry
WO2009043848A3 (en) Use of the serological assay of the cytokine b-lymphocyte stimulator (blys) for the diagnosis, prognosis and the screening of therapeutic efficacy in immune-related diseases including organ-specific autoimmune diseases and transfusion reactions
Rosli et al. Measurement comparability of insulin assays using conventional immunoassay kits
EP1143251A4 (en) METHOD AND BIOSENSOR FOR DETECTING ANTIGENS
Cysique et al. The kynurenine pathway relates to post‐acute COVID‐19 objective cognitive impairment and PASC
ATE377758T1 (de) Neurotoxische aminosäure oder neurotoxisches derivat davon im zusammenhang mit neurologischen störungen
EP1871894A4 (en) COMBINATION OF 1,5-ANHYDROGLUCITOL (1,5-AG) ASSAY AND A1C / 1.5-AG ASSAY TO MEASURE BLOOD SUGAR DEVIATIONS GENERALLY AND POSTPRANDIAL HYPERGLYCEMIA IN DIABETES PATIENTS
DE602004030938D1 (de) Probennahmeautomat mit hohem durchsatz
Krieg et al. An MRM-based multiplexed quantification assay for human adipokines and apolipoproteins
EP1681567A4 (en) SAMPLE PRETREATMENT METHOD AND IMMUNOLOGICAL ASSAY METHOD USING THE SAME
WO2002066982A3 (de) Analyse von modifizierungen und demodifizierungen von proteinen mit ubiquintin-verwandten proteinen mittels fret (fluorescence resonance energy transfer)
Then et al. Association of renin and aldosterone with glucose metabolism in a Western European population: the KORA F4/FF4 study